FAMICORD AG (V3V.DE) Stock Fundamental Analysis
FRA:V3V - Deutsche Boerse Ag - DE000A0BL849 - Common Stock - Currency: EUR
V3V gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 24 industry peers in the Health Care Providers & Services industry. V3V has a bad profitability rating. Also its financial health evaluation is rather negative. V3V has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year V3V was profitable.
V3V had a positive operating cash flow in the past year.
In multiple years V3V reported negative net income over the last 5 years.
Of the past 5 years V3V 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.61%, V3V is in line with its industry, outperforming 54.17% of the companies in the same industry.
V3V's Return On Equity of 10.63% is fine compared to the rest of the industry. V3V outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 10.63% | ||
| ROIC | N/A |
ROA(3y)-7.04%
ROA(5y)-3.48%
ROE(3y)-60.2%
ROE(5y)-34.49%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
V3V's Profit Margin of 3.20% is fine compared to the rest of the industry. V3V outperforms 66.67% of its industry peers.
Looking at the Gross Margin, with a value of 36.66%, V3V is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
In the last couple of years the Gross Margin of V3V has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 3.2% | ||
| GM | 36.66% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.67%
GM growth 5Y-8.9%
2. Health
2.1 Basic Checks
V3V does not have a ROIC to compare to the WACC, probably because it is not profitable.
V3V has more shares outstanding than it did 1 year ago.
The number of shares outstanding for V3V has been increased compared to 5 years ago.
Compared to 1 year ago, V3V has an improved debt to assets ratio.
2.2 Solvency
V3V has an Altman-Z score of 0.45. This is a bad value and indicates that V3V is not financially healthy and even has some risk of bankruptcy.
V3V's Altman-Z score of 0.45 is on the low side compared to the rest of the industry. V3V is outperformed by 70.83% of its industry peers.
The Debt to FCF ratio of V3V is 2.09, which is a good value as it means it would take V3V, 2.09 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.09, V3V belongs to the best of the industry, outperforming 95.83% of the companies in the same industry.
A Debt/Equity ratio of 0.56 indicates that V3V is somewhat dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.56, V3V belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 2.09 | ||
| Altman-Z | 0.45 |
ROIC/WACCN/A
WACC6.19%
2.3 Liquidity
V3V has a Current Ratio of 0.76. This is a bad value and indicates that V3V is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of V3V (0.76) is worse than 62.50% of its industry peers.
A Quick Ratio of 0.70 indicates that V3V may have some problems paying its short term obligations.
With a Quick ratio value of 0.70, V3V perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 109.51% over the past year.
Looking at the last year, V3V shows a small growth in Revenue. The Revenue has grown by 7.73% in the last year.
Measured over the past years, V3V shows a very strong growth in Revenue. The Revenue has been growing by 30.44% on average per year.
EPS 1Y (TTM)109.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
Revenue 1Y (TTM)7.73%
Revenue growth 3Y57.65%
Revenue growth 5Y30.44%
Sales Q2Q%8.91%
3.2 Future
Based on estimates for the next years, V3V will show a very strong growth in Earnings Per Share. The EPS will grow by 32.64% on average per year.
Based on estimates for the next years, V3V will show a small growth in Revenue. The Revenue will grow by 2.88% on average per year.
EPS Next Y58.33%
EPS Next 2Y35.4%
EPS Next 3Y32.64%
EPS Next 5YN/A
Revenue Next Year9.33%
Revenue Next 2Y6.14%
Revenue Next 3Y5.07%
Revenue Next 5Y2.88%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 29.43, V3V can be considered very expensive at the moment.
Based on the Price/Earnings ratio, V3V is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of V3V to the average of the S&P500 Index (28.98), we can say V3V is valued inline with the index average.
V3V is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.43 | ||
| Fwd PE | N/A |
4.2 Price Multiples
V3V's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. V3V is cheaper than 70.83% of the companies in the same industry.
70.83% of the companies in the same industry are more expensive than V3V, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.1 | ||
| EV/EBITDA | 8.59 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as V3V's earnings are expected to grow with 32.64% in the coming years.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y35.4%
EPS Next 3Y32.64%
5. Dividend
5.1 Amount
No dividends for V3V!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:V3V (4/28/2025, 7:00:00 PM)
4.12
+0.02 (+0.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners2.65%
Inst Owner ChangeN/A
Ins Owners58.45%
Ins Owner ChangeN/A
Market Cap72.68M
Analysts84
Price Target6.43 (56.07%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)37.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.43 | ||
| Fwd PE | N/A | ||
| P/S | 0.9 | ||
| P/FCF | 8.1 | ||
| P/OCF | 6 | ||
| P/B | 2.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.59 |
EPS(TTM)0.14
EY3.4%
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.51
FCFY12.35%
OCF(TTM)0.69
OCFY16.66%
SpS4.57
BVpS1.38
TBVpS-1.68
PEG (NY)0.5
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 10.63% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 3.2% | ||
| GM | 36.66% | ||
| FCFM | 11.13% |
ROA(3y)-7.04%
ROA(5y)-3.48%
ROE(3y)-60.2%
ROE(5y)-34.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.67%
GM growth 5Y-8.9%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 2.09 | ||
| Debt/EBITDA | 1.65 | ||
| Cap/Depr | 35.61% | ||
| Cap/Sales | 3.89% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 147.25% | ||
| Profit Quality | 347.6% | ||
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 0.45 |
F-Score7
WACC6.19%
ROIC/WACCN/A
Cap/Depr(3y)60.39%
Cap/Depr(5y)47.49%
Cap/Sales(3y)7.53%
Cap/Sales(5y)6.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
EPS Next Y58.33%
EPS Next 2Y35.4%
EPS Next 3Y32.64%
EPS Next 5YN/A
Revenue 1Y (TTM)7.73%
Revenue growth 3Y57.65%
Revenue growth 5Y30.44%
Sales Q2Q%8.91%
Revenue Next Year9.33%
Revenue Next 2Y6.14%
Revenue Next 3Y5.07%
Revenue Next 5Y2.88%
EBIT growth 1Y97.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year562.86%
EBIT Next 3Y98.56%
EBIT Next 5YN/A
FCF growth 1Y198.46%
FCF growth 3Y20.6%
FCF growth 5Y6%
OCF growth 1Y520.19%
OCF growth 3Y37.37%
OCF growth 5Y14.78%